Evidence map›Paper›PMID 24828189›Full record

ReviewNature2014

Nucleotide signalling during inflammation.

Marco Idzko, Davide Ferrari, Holger K Eltzschig

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03516903 (Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After ST-elevation Myocardial Infarction), which is not on this map. Cited by 505 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
505citing papers in PubMed, 1 pooled it
66.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03516903 phase2 / phase3terminatednot on this mapstarted 2018, after this paper: background citation

Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After ST-elevation Myocardial Infarction

TypeinterventionalSponsorUniversity of Sao PauloRan2018 to 2020Enrolled35ConditionsMyocardial Infarction, Anterior Wall, Myocardial Remodeling, VentricularArmsMethotrexate, Placebo, Folic Acid
3 · Its place in the literature

Who cites it

505 citing papers in PubMed, 1 synthesis or guideline pooled it, 888 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Neuroglial P2YJournal of neuroinflammation · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

445 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marco IdzkoDepartment of Pneumology, Freiburg University Medical Center, Albert-Ludwigs-University, 79106 Freiburg, Germany.
Davide FerrariDepartment of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, 44121, Italy.
Holger K EltzschigOrgan Protection Program, Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.
University of Ferrara · IT

Funding

Trangenic Mouse Breeding CoreP01HL114457 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHANG, YUJIN · 2013 to 2017
$10.0M
Extracellular Adenosine During Ventilator Induced Lung InjuryR01HL092188 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2009 to 2013
$2.1M
Proton Pump Inhibitors for Perioperative Acute Kidney InjuryR01DK097075 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2013 to 2017
$1.7M
Hypoxia Inducible Factor in Acute Lung InjuryR01HL098294 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2011 to 2014
$1.6M
Alternative Mechanisms of Adenosine Receptor ActivationR01DK083385 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2010 to 2013
$1.2M
NHLBI NIH HHS P01 HL114457NHLBI NIH HHS P01HL114457-01NHLBI NIH HHS R01-HL0921NHLBI NIH HHS R01 HL092188NHLBI NIH HHS R01 HL098294NHLBI NIH HHS R01-HL098294NIDDK NIH HHS R01 DK083385NIDDK NIH HHS R01-DK083385NIDDK NIH HHS R01 DK097075NIDDK NIH HHS R01-DK097075
6 · The paper itself

Abstract

Inflammatory conditions are associated with the extracellular release of nucleotides, particularly ATP. In the extracellular compartment, ATP predominantly functions as a signalling molecule through the activation of purinergic P2 receptors. Metabotropic P2Y receptors are G-protein-coupled, whereas ionotropic P2X receptors are ATP-gated ion channels. Here we discuss how signalling events through P2 receptors alter the outcomes of inflammatory or infectious diseases. Recent studies implicate a role for P2X/P2Y signalling in mounting appropriate inflammatory responses critical for host defence against invading pathogens or tumours. Conversely, P2X/P2Y signalling can promote chronic inflammation during ischaemia and reperfusion injury, inflammatory bowel disease or acute and chronic diseases of the lungs. Although nucleotide signalling has been used clinically in patients before, research indicates an expanding field of opportunities for specifically targeting individual P2 receptors for the treatment of inflammatory or infectious diseases.

Indexed as

Signal TransductionAdenosine TriphosphateAnimalsHumansInfectionsInflammationIon ChannelsNeoplasmsPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2Adenosine TriphosphateIon ChannelsPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2

Identifiers

PMID24828189
PMCPMC4222675
OpenAlexW1979412100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.